Xencor XNCR
NASDAQ XNCR
$26.61 -0.01 (-0.04%)
As of: Sep 4, 2026 · 3:59 PM EDT

Xencor (XNCR) Total Current Liabilities (2013 - 2026)

Xencor (XNCR) posted quarterly Total Current Liabilities of $73.5 million for Q1 2026, down 16.94% year-over-year from $88.4 million in Q1 2025, and down 23.41% quarter-over-quarter from $95.9 million in Q4 2025.

Analysis

Xencor (XNCR) Total Current Liabilities (2013 - 2026) Analysis & Trends

Xencor (XNCR) has reported Total Current Liabilities for 14 consecutive years, with $73.5 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Total Current Liabilities fell 16.94% year-over-year to $73.5 million; the TTM figure through Mar 2026 stood at $73.5 million (down 16.94% YoY), while the FY2025 annual figure was $95.9 million, up 9.69% from the prior year.
  • Total Current Liabilities declined to $73.5 million in Q1 2026 per XNCR's latest filing, from $95.9 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $96.1 million in Q2 2025 and bottomed at $44.6 million in Q2 2023.
  • Historically, Total Current Liabilities has averaged $76.0 million across 5 years, with a median of $75.0 million in 2022.
  • Annual changes were most pronounced in 2022 — Total Current Liabilities soared 103.15% — and 2023, when it slumped 41.09%.
  • Xencor's Total Current Liabilities stood at $63.8 million in 2022, then advanced by 15.77% to $73.9 million in 2023, then advanced by 18.29% to $87.4 million in 2024, then advanced by 9.69% to $95.9 million in 2025, then dropped by 23.41% to $73.5 million in 2026.
  • Business Quant data shows XNCR's Total Current Liabilities at $73.5 million in Q1 2026, $95.9 million in Q4 2025, and $86.5 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 3.94 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 5.53 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.58 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 2.53 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 354.06 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 2.12 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 1.51 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 630.93 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 438.74 Mn
10 Xencor 2.02 Bn 1.65 Bn - 81.87 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 81.87 Mn
Mar 31, 2026 73.46 Mn
Dec 31, 2025 95.91 Mn
Sep 30, 2025 86.49 Mn
Jun 30, 2025 96.08 Mn
Mar 31, 2025 88.44 Mn
Dec 31, 2024 87.43 Mn
Sep 30, 2024 90.81 Mn
Jun 30, 2024 75.59 Mn
Mar 31, 2024 71.08 Mn
Dec 31, 2023 73.92 Mn
Sep 30, 2023 53.04 Mn
Jun 30, 2023 44.63 Mn
Mar 31, 2023 65.06 Mn
Dec 31, 2022 63.84 Mn
Sep 30, 2022 90.03 Mn
Jun 30, 2022 75.04 Mn
Mar 31, 2022 60.94 Mn
Dec 31, 2021 70.74 Mn
Sep 30, 2021 44.32 Mn